Učitavanje...
Regular treatment with formoterol for chronic asthma: serious adverse events
BACKGROUND: Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe. OBJECTIVES: The aim of this review is...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4017186/ https://ncbi.nlm.nih.gov/pubmed/22513944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006923.pub3 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|